# Intrathecal Dexmedetomidine Versus Transversus Abdominus Plane Block (TAP) for Postoperative Analgesia After Cesarean Section.

> **NCT04969705** · NA · COMPLETED · sponsor: **Sohag University** · enrollment: 60 (actual)

## Conditions studied

- Pain Management in Adult Females in Child Bearing Period Aging From 20 to 45 Years Who Are Scheduled for Elective Cesarean Section

## Interventions

- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT04969705
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-01
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-03-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04969705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04969705, "Intrathecal Dexmedetomidine Versus Transversus Abdominus Plane Block (TAP) for Postoperative Analgesia After Cesarean Section.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04969705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*